Investor Update
Ad hoc announcement pursuant to Art. 53 LR Basel, 20 October 2021 Roche reports strong growth in the first nine months – outlook for 2021 raised Group sales up 8%1 at constant exchange rates (CER); 6% in Swiss francs Pharmaceuticals Division sales grow 5% in the third quarter and are now in line with the prior year for
Download Investor Update
Information
Domain:
Source:
Link to this page:
Documents from same domain
Roche Supplier Code of Conduct
www.roche.comThe Roche Supplier Code of Conduct was proposed by the Corporate Sustainability Committee and was adopted by the Corporate Executive Committee on …
‘Operational Excellence’ - Roche
www.roche.com‘Operational Excellence’ – ... Communication, Legal Commercial - ROW Group Functions1 G&A/Procurement Moderate impact Strong impact gRED pRED Pharma Partnering Pharma Medicines. 7 Financial impact Expected savings of CHF 2.4 billion by 20121 2011 2012 Pharma Medicines 1’830 2’440 pRED Other2 Group Functions
Roche Holdings, Inc. Annual Report 2020
www.roche.combiosimilar erosion as well as market contractions due to COVID-19 particularly for Rituxan, partly compensated by the uptake of new medicines. The Diagnostics Division reported a sales growth of 28% to USD 4.9 billion, due to sales of COVID-19-related tests, notably the cobas SARS-CoV-2 PCR test, which more than offset a decline in routine testing
A YEAR IN REVIEW - Roche
www.roche.comrenowned academic researchers banded together to battle a disease that knows no borders. The collaboration is called Accelerating COVID-19 Therapeutic Interventions and Vaccines, or ACTIV. The effort, led by the National Institutes of Health (NIH) and the Foundation for the NIH, is a public-private partnership of truly pandemic proportions.
Related documents
Summary of Economic Projections - Federal Reserve
www.federalreserve.govJun 16, 2021 · For release at 2:00 p.m., EDT, June 16, 2021 Table 1. Economic projections of Federal Reserve Board members and Federal Reserve Bank presidents,
Level of Service/Case Management Inventory (LS/CMI ...
www.pccd.pa.govLevel of Service/Case Management Inventory (LS/CMI) Profile and Associated Costs Background Information: The LS/CMI is the “fourth generation” revision (see appendix A to learn about 3rd and 4th generation instruments) of the LSI-R that provides a comprehensive measure of offender risk, needs, and responsivity (RNR) factors, as well as a fully functional